Cecchini Michele, Sassi Franco
Institute of Global Health Innovation, Imperial College London, London, UK,
Pharmacoeconomics. 2015 Jul;33(7):765-76. doi: 10.1007/s40273-015-0301-z.
With more than two-thirds of the US population overweight or obese, the obesity epidemic is a major threat for population health and the financial sustainability of the healthcare service. Whether, and to what extent, effective prevention interventions may offer the opportunity to 'bend the curve' of rising healthcare costs is still an object of debate.
This study evaluates the potential economic impact of a set of prevention programmes, including education, counselling, long-term drug treatment, regulation (e.g. of advertising or labelling) and fiscal measures, on national healthcare expenditure and use of healthcare services in the USA.
The study was carried out as a retrospective evaluation of alternative scenarios compared with a 'business as usual' scenario. An advanced econometric approach involving the use of logistic regression and generalized linear models was used to calculate the number of contacts with key healthcare services (inpatient, outpatient, drug prescriptions) and the associated cost. Analyses were carried out on the Medical Expenditure Panel Survey (1997-2010).
In 2010, prevention interventions had the potential to decrease total healthcare expenditure by up to $US2 billion. This estimate does not include the implementation costs. The largest share of savings is produced by reduced use and costs of inpatient care, followed by reduced use of drugs. Reduction in expenditure for outpatient care would be more limited. Private insurance schemes benefit from the largest savings in absolute terms; however, public insurance schemes benefit from the largest cost reduction per patient. People in the lowest income groups show the largest economic benefits.
Prevention interventions aimed at tackling obesity and associated risk factors may produce a significant decrease in the use of healthcare services and expenditure. Savings become substantial when a long-term perspective is taken.
美国超过三分之二的人口超重或肥胖,肥胖流行对民众健康和医疗服务的财务可持续性构成重大威胁。有效的预防干预措施是否以及在多大程度上能够为扭转医疗成本上升的“曲线”提供机会,仍是一个争论的焦点。
本研究评估一系列预防计划,包括教育、咨询、长期药物治疗、监管(如广告或标签)和财政措施,对美国国家医疗支出和医疗服务使用的潜在经济影响。
该研究是对与“照常营业”情景相比的替代情景进行回顾性评估。采用了一种先进的计量经济学方法,涉及使用逻辑回归和广义线性模型来计算与关键医疗服务(住院、门诊、药物处方)的接触次数及相关成本。分析基于医疗支出面板调查(1997 - 2010年)进行。
2010年,预防干预措施有可能使医疗总支出减少高达20亿美元。这一估计不包括实施成本。节省的最大份额来自住院护理使用和成本的降低,其次是药物使用的减少。门诊护理支出的减少将较为有限。私人保险计划在绝对节省金额方面受益最大;然而,公共保险计划在每位患者的成本降低方面受益最大。收入最低群体的人显示出最大的经济利益。
旨在解决肥胖及相关风险因素的预防干预措施可能会使医疗服务的使用和支出显著减少。从长期来看,节省的费用相当可观。